Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, improves glycemic control in type 2 diabetes mellitus patients (T2DM)

被引：0
|
作者：
Abou-Donia, M
Fiedorek, FT
Wilson, GG
Frith, L
Patel, J
机构：
[1] Glaxo Wellcome Co, Res Triangle Pk, NC USA
[2] PPA20005 Study Grp, Greenford, Middx, England
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
726
引用
收藏
页码：A189 / A189
页数：1
相关论文
共 50 条
  • [31] Patterns of oral antihyperglycemic therapy and level of glycemic control among patients with Type 2 diabetes mellitus (T2DM) in Malaysia
    Chan, Siew Pheng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S69 - S69
  • [32] Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
    Hollander, Priscilla
    Li, Jia
    Allen, Elsie
    Chen, Roland
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12): : 4810 - 4819
  • [33] Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled study
    Fonseca, VA
    Valiquett, TR
    Huang, SM
    Ghazzi, MN
    Whitcomb, RW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09): : 3169 - 3176
  • [34] Ipragliflozin improves glycemic control in Japanese patients with type 2 diabetes mellitus: the BRIGHTEN study: BRIGHTEN: double-blind randomized study of ipragliflozin to show its efficacy as monotherapy in T2DM patients
    Kashiwagi A.
    Kazuta K.
    Takinami Y.
    Yoshida S.
    Utsuno A.
    Nagase I.
    Diabetology International, 2015, 6 (1) : 8 - 18
  • [35] Are Chromium (Cr) Supplements Efficacious for Glycemic Control in Type 2 Diabetes (T2DM)?
    Dwyer, Johanna T.
    Costello, R. B.
    Bailey, R. L.
    Wambogo, E.
    FASEB JOURNAL, 2016, 30
  • [36] Two-Year Use of Exenatide Once Weekly in Type 2 Diabetes Mellitus (T2DM) Patients Taking Thiazolidinedione
    Trautmann, Michael
    Norwood, Paul
    Pintilei, Ella
    Liutkus, Joanne
    Haber, Harry
    Boardman, Marilyn
    DIABETES, 2012, 61 : A293 - A293
  • [37] Gastric electrical stimulation (TANTALUS-TM) improves glycemic control in morbidly obese patients with type 2 diabetes (T2DM)
    Ludvik, Bernhard
    Prager, Gerhard
    Weiner, Rudolf
    Rosak, Christoph
    DIABETES, 2007, 56 : A164 - A164
  • [38] Sitagliptin monotherapy improved glycemic control and beta-cell function after 18 weeks in patients with type 2 diabetes (T2DM)
    Raz, Itamar
    Hanefeld, Markolf
    Xu, Lei
    Caria, Christine
    Davies, Michael
    Williams-Herman, Debora
    Khatami, Hootan
    DIABETES, 2006, 55 : A462 - A462
  • [39] Perspectives on Stringent Glycemic Control and Weight Loss among People with Type 2 Diabetes Mellitus (T2DM) in China
    Zhang, Jian
    Li, Ang
    Quan, Jinxing
    Wu, Jun
    Cai, Hanqing
    Ding, Yuchen
    Tang, Jiani
    Ma, Xiao
    Zhang, Junqing
    DIABETES, 2024, 73
  • [40] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345